Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker

JP Clozel, EA Ertel, SI Ertel - Journal of hypertension, 1997 - journals.lww.com
JP Clozel, EA Ertel, SI Ertel
Journal of hypertension, 1997journals.lww.com
Properties of mibefradil Mibefradil is a novel calcium chan-nel antagonist with structural and
pharmacological characteristics clearly distinct from those of classical calcium antagonists. It
is a potent vasodilator with a high selectivity for the coronary vasculature over the peripheral
vasculature and the myocardium. Most importantly, this compound can relax vascular
muscle and slow the heart rate without reducing cardiac contractility. In addition, it does not
stimulate neurohormonal reflexes and it exhibits a good pharmacological profile …
Properties of mibefradil Mibefradil is a novel calcium chan-nel antagonist with structural and pharmacological characteristics clearly distinct from those of classical calcium antagonists. It is a potent vasodilator with a high selectivity for the coronary vasculature over the peripheral vasculature and the myocardium. Most importantly, this compound can relax vascular muscle and slow the heart rate without reducing cardiac contractility. In addition, it does not stimulate neurohormonal reflexes and it exhibits a good pharmacological profile characterized by a long duration of action.
Lippincott Williams & Wilkins